A drug used to treat men with late -
stage prostate cancer proved effective in stemming progression of the disease in research participants who had not yet received chemotherapy and extended their survival, according to results from a multi-national Phase III clinical trial led by the Knight Cancer Institute at Oregon Health & Science University (OHSU).
Dr. Dean Ornish revolutionized medicine by directing clinical research
proving — for the first time — that heart disease and early -
stage prostate cancer may be stopped or even reversed by his program of comprehensive lifestyle changes, without drugs or surgery.